annual accounts payable:
$9.81M+$2.30M(+30.63%)Summary
- As of today (May 29, 2025), VKTX annual accounts payable is $9.81 million, with the most recent change of +$2.30 million (+30.63%) on December 31, 2024.
- During the last 3 years, VKTX annual accounts payable has risen by +$8.37 million (+579.57%).
- VKTX annual accounts payable is now at all-time high.
Performance
VKTX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$7.70M-$2.11M(-21.51%)Summary
- As of today (May 29, 2025), VKTX quarterly accounts payable is $7.70 million, with the most recent change of -$2.11 million (-21.51%) on March 31, 2025.
- Over the past year, VKTX quarterly accounts payable has increased by +$2.48 million (+47.41%).
- VKTX quarterly accounts payable is now -30.55% below its all-time high of $11.09 million, reached on June 30, 2024.
Performance
VKTX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VKTX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.6% | +47.4% |
| 3 y3 years | +579.6% | +146.9% |
| 5 y5 years | +303.7% | +148.6% |
VKTX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +579.6% | -30.6% | +2932.3% |
| 5 y | 5-year | at high | +579.6% | -30.6% | +2932.3% |
| alltime | all time | at high | >+9999.0% | -30.6% | +2932.3% |
VKTX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $7.70M(-21.5%) |
| Dec 2024 | $9.81M(+30.6%) | $9.81M(+3763.4%) |
| Sep 2024 | - | $254.00K(-97.7%) |
| Jun 2024 | - | $11.09M(+112.2%) |
| Mar 2024 | - | $5.22M(-30.4%) |
| Dec 2023 | $7.51M(-11.9%) | $7.51M(+31.5%) |
| Sep 2023 | - | $5.71M(+1.8%) |
| Jun 2023 | - | $5.61M(+47.7%) |
| Mar 2023 | - | $3.80M(-55.5%) |
| Dec 2022 | $8.53M(+490.7%) | $8.53M(+171.5%) |
| Sep 2022 | - | $3.14M(-48.5%) |
| Jun 2022 | - | $6.10M(+95.7%) |
| Mar 2022 | - | $3.12M(+116.0%) |
| Dec 2021 | $1.44M(-63.8%) | $1.44M(-49.4%) |
| Sep 2021 | - | $2.85M(-32.3%) |
| Jun 2021 | - | $4.21M(-13.2%) |
| Mar 2021 | - | $4.85M(+21.6%) |
| Dec 2020 | $3.99M(+64.0%) | $3.99M(+44.7%) |
| Sep 2020 | - | $2.76M(-14.1%) |
| Jun 2020 | - | $3.21M(+3.6%) |
| Mar 2020 | - | $3.10M(+27.4%) |
| Dec 2019 | $2.43M | $2.43M(+16.0%) |
| Sep 2019 | - | $2.10M(+12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $1.87M(+11.6%) |
| Mar 2019 | - | $1.68M(+74.8%) |
| Dec 2018 | $959.00K(-37.3%) | $959.00K(-21.1%) |
| Sep 2018 | - | $1.22M(-18.6%) |
| Jun 2018 | - | $1.49M(+126.9%) |
| Mar 2018 | - | $658.00K(-57.0%) |
| Dec 2017 | $1.53M(+27.0%) | $1.53M(-1.7%) |
| Sep 2017 | - | $1.56M(+19.2%) |
| Jun 2017 | - | $1.30M(-24.4%) |
| Mar 2017 | - | $1.73M(+43.4%) |
| Dec 2016 | $1.20M(+103.2%) | $1.20M(+36.6%) |
| Sep 2016 | - | $881.30K(-26.9%) |
| Jun 2016 | - | $1.21M(+2.9%) |
| Mar 2016 | - | $1.17M(+97.9%) |
| Dec 2015 | $592.40K(-67.6%) | $592.40K(+47.5%) |
| Sep 2015 | - | $401.70K(-60.2%) |
| Jun 2015 | - | $1.01M(-46.3%) |
| Mar 2015 | - | $1.88M(+2.7%) |
| Dec 2014 | $1.83M(+2370.6%) | $1.83M(+29.3%) |
| Jun 2014 | - | $1.42M(+273.5%) |
| Mar 2014 | - | $379.20K |
| Dec 2013 | $74.10K(+37.2%) | - |
| Dec 2012 | $54.00K | - |
FAQ
- What is Viking Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Viking Therapeutics?
- What is Viking Therapeutics annual accounts payable year-on-year change?
- What is Viking Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Viking Therapeutics?
- What is Viking Therapeutics quarterly accounts payable year-on-year change?
What is Viking Therapeutics annual accounts payable?
The current annual accounts payable of VKTX is $9.81M
What is the all time high annual accounts payable for Viking Therapeutics?
Viking Therapeutics all-time high annual accounts payable is $9.81M
What is Viking Therapeutics annual accounts payable year-on-year change?
Over the past year, VKTX annual accounts payable has changed by +$2.30M (+30.63%)
What is Viking Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VKTX is $7.70M
What is the all time high quarterly accounts payable for Viking Therapeutics?
Viking Therapeutics all-time high quarterly accounts payable is $11.09M
What is Viking Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VKTX quarterly accounts payable has changed by +$2.48M (+47.41%)